MedTech Acquisition Corporation Unit
MTACU
MTACU was delisted on the 10th of August, 2023.
62 hedge funds and large institutions have $245M invested in MedTech Acquisition Corporation Unit in 2020 Q4 according to their latest regulatory filings, with 62 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$28.7M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$20.4M |
| 3 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$17.7M |
| 4 |
HP
Hartree Partners
New York
|
+$14.4M |
| 5 |
PWAM
Park West Asset Management
San Francisco,
California
|
+$13M |
Top Sellers
MTACU Hedge Fund Activity: Q4 2020 in Review
62 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in MedTech Acquisition Corporation Unit (MTACU) for Q4 2020, worth a combined $245M.
Buyers outnumbered sellers: 62 funds opened new MTACU positions and 0 closed out — a net gain of 62 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was BlackRock, opening a new position worth an estimated $28.7M.
- 62 institutional investors held MedTech Acquisition Corporation Unit (MTACU) as of Q4 2020, up from 0 in Q3 2020.
- Funds reported $245M of MedTech Acquisition Corporation Unit stock for Q4 2020.
- 62 funds opened new MedTech Acquisition Corporation Unit positions in Q4 2020 and 0 closed out, a net change of +62 holders.
- The largest MedTech Acquisition Corporation Unit buyer in Q4 2020 was BlackRock, an estimated $28.7M added.
Based on aggregated 13F filings for Q4 2020.